Explore how engineered nanoparticles are revolutionizing hepatocellular carcinoma treatment through precision targeting, improved imaging, and combination therapies.
Discover how growth hormone receptor (GHR) failure transforms liver cancer into a relentless aggressor and rewrites survival predictions in hepatocellular carcinoma.